Cotton Warns Of Reckoning For China Over How It ‘Unleashed This Plague’

WASHINGTON, DC - JANUARY 21: Sen. Tom Cotton (R-AR) walks to the Senate floor for the start of impeachment trial proceedings at the U.S. Capitol on January 21, 2020 in Washington, DC. The Senate impeachment trial of ... WASHINGTON, DC - JANUARY 21: Sen. Tom Cotton (R-AR) walks to the Senate floor for the start of impeachment trial proceedings at the U.S. Capitol on January 21, 2020 in Washington, DC. The Senate impeachment trial of U.S. President Donald Trump resumes on Tuesday. (Photo by Drew Angerer/Getty Images) MORE LESS
Start your day with TPM.
Sign up for the Morning Memo newsletter

Sen. Tom Cotton (R-AR) warned of a “reckoning” for China after the U.S. emerges from the coronavirus pandemic, during an interview on “Fox & Friends” Wednesday morning.

When asked by co-host Steve Doocy about an op-ed he wrote with Rep. Mike Gallagher (R-WI) for Fox News, which argues that China stole U.S. capacity to produce pharmaceuticals and medical devices, Cotton reiterated the need to bring manufacturing capacity back to the country in the midst of what he and Gallagher called the “China virus pandemic.”

“It’s time to bring that manufacturing capacity back to the United States,” Cotton said, referring to how China produces antibiotics, ibuprofen and Advil.

Cotton then said that “it’s time to bring a lot more back” to the U.S. from China before adding that a “reckoning” is imminent.

“China unleashed this plague on the world and there will be a reckoning when we’re on the back side of it,” Cotton said, without elaborating.

Cotton’s latest remarks come after President Trump defended labeling the outbreak the “Chinese virus” last week. Less than a week later, Trump attempted to defend the Asian-American community for the xenophobia it has faced in the wake of COVID-19 coverage.

Watch Cotton’s remarks below:

Latest News
Comments
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: